- Home
- DLTH vs RPTX Comparison
DLTH vs RPTX Comparison
Compare DLTH & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- RPTX
- Stock Information
- Founded
- DLTH 1989
- RPTX 2016
- Country
- DLTH United States
- RPTX Canada
- Employees
- DLTH N/A
- RPTX N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- DLTH Consumer Discretionary
- RPTX Health Care
- Exchange
- DLTH Nasdaq
- RPTX Nasdaq
- Market Cap
- DLTH 131.0M
- RPTX 119.7M
- IPO Year
- DLTH 2015
- RPTX 2020
- Fundamental
- Price
- DLTH $4.20
- RPTX $3.35
- Analyst Decision
- DLTH Hold
- RPTX Strong Buy
- Analyst Count
- DLTH 1
- RPTX 2
- Target Price
- DLTH $4.50
- RPTX $17.50
- AVG Volume (30 Days)
- DLTH 73.4K
- RPTX 129.9K
- Earning Date
- DLTH 11-29-2024
- RPTX 11-07-2024
- Dividend Yield
- DLTH N/A
- RPTX N/A
- EPS Growth
- DLTH N/A
- RPTX N/A
- EPS
- DLTH N/A
- RPTX N/A
- Revenue
- DLTH $642,126,000.00
- RPTX $68,683,000.00
- Revenue This Year
- DLTH $0.98
- RPTX $16.85
- Revenue Next Year
- DLTH $1.28
- RPTX N/A
- P/E Ratio
- DLTH N/A
- RPTX N/A
- Revenue Growth
- DLTH N/A
- RPTX N/A
- 52 Week Low
- DLTH $3.09
- RPTX $2.71
- 52 Week High
- DLTH $5.82
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- DLTH 66.37
- RPTX 50.49
- Support Level
- DLTH $3.89
- RPTX $3.07
- Resistance Level
- DLTH $3.88
- RPTX $3.45
- Average True Range (ATR)
- DLTH 0.14
- RPTX 0.21
- MACD
- DLTH 0.03
- RPTX -0.02
- Stochastic Oscillator
- DLTH 100.00
- RPTX 36.36
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar Mocs, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.